3-Iodothyronamine

3-Iodothyronamine (T1AM) is a derivative of the thyroid hormone thyroxine (T4). It is an endogenous biogenic amine that has been identified as a novel signaling molecule with distinct physiological effects.

Structure and Synthesis

3-Iodothyronamine is structurally related to the thyroid hormones, but it differs by the presence of an iodine atom and an amine group. It is synthesized from thyroxine through a series of enzymatic reactions that involve the removal of the carboxyl group and the phenolic hydroxyl group.

Mechanism of Action

3-Iodothyronamine acts primarily through the trace amine-associated receptor 1 (TAAR1), a G protein-coupled receptor (GPCR). Activation of TAAR1 by T1AM leads to various intracellular signaling cascades, which can influence metabolism, thermoregulation, and cardiovascular function.

Physiological Effects

T1AM has been shown to have several physiological effects, including:

• Metabolic Regulation: T1AM can induce a hypometabolic state, characterized by decreased body temperature and oxygen consumption.
• Cardiovascular Effects: It can influence heart rate and blood pressure, often causing a decrease in heart rate (bradycardia).
• Neurological Effects: T1AM has been implicated in modulating neurotransmitter systems, potentially affecting mood and behavior.

Potential Therapeutic Applications

Due to its unique effects on metabolism and cardiovascular function, 3-Iodothyronamine is being investigated for potential therapeutic applications in conditions such as obesity, heart failure, and neurodegenerative diseases.

Research and Development

Research on 3-Iodothyronamine is ongoing, with studies focusing on its role in endocrinology, its potential as a therapeutic agent, and its broader implications in physiology.

Related pages

• Thyroid hormone
• Thyroxine
• Biogenic amine
• Trace amine-associated receptor 1

Gallery

• 
  Chemical structure of 3-Iodothyronamine
• 
  3D ball-and-stick model of 3-Iodothyronamine